COMMUNIQUÉ DE PRESSE
News
-
-
-
-
COMMUNIQUÉ DE PRESSE
RÉSULTATS ANNUELS 2024/25 : UNE PERFORMANCE SOLIDE, DANS UN MARCHÉ EN REPLI
Le Groupe Fountaine Pajot publie des résultats solides pour l'exercice 2024/25, préservant sa rentabilité et renforçant sa solidité financière. Des investissements ambitieux sont prévus pour les 50 ans de l'entreprise -
-
-
-
COMMUNIQUÉ DE PRESSE
Aramis Group - Declaration of transactions on own shares conducted from Dec 15 to Dec 19, 2025
Aramis Group declares recent purchases of own shares (FR0014003U94) conducted from December 15 to December 19, 2025, in compliance with regulations. More details on the transactions available on their website -
-
COMMUNIQUÉ DE PRESSE
AB Science patent for masitinib in the treatment of sickle cell disease formally granted in the US with a protection until 2040
AB Science's patent for masitinib in the treatment of sickle cell disease is formally granted in the United States, providing long-term protection until 2040. The biomarker Phase 2 in cooperation with AP-HP is fully funded
